Public Release: 

Largest ever collection of patient data of inherited epilepsy conditions

Swansea University

Researchers from Swansea University Medical School have joined up with five other centres from around the world to compile the biggest recorded collection of families with forms of epilepsy where genetics may play a part in the recurring feature of the condition.

The aim was to determine if specific clinical epilepsy features aggregate within families and whether this may constitute distinct family syndromes that could inform on subsequent genetic research.

The study involved epilepsy researchers from six Centres (Melbourne, Swansea, Montreal, Columbia University, Dublin and Otago) assembling a cohort of 'genetically enriched' common epilepsies by collecting families containing multiple individuals with unprovoked seizures. 303 families with three or more individuals with unprovoked seizures were included in this study and collected across the six Centres and as part of the Epi4K consortium. Twenty-eight families collected from across Wales by the Neurology Research team met the study criteria.

Clinical analysis of the 303 families revealed that families had a range of epilepsies that were the same by diagnosis but also had mixed forms of epilepsy. In addition some familial epilepsies, that were regarded as rare, are more common than had been appreciated. Also by having well-characterised families this will help in the search for epilepsy genes - a search which is underway at the Columbia University Institute of Genomic Medicine.

Speaking about the research Professor Mark Rees, Swansea University said:

"This is the first time that an analysis of this scale has focussed on common familial epilepsies. My Swansea University colleagues Dr Owen Pickrell and alumnus Dr Rhys Thomas (now University of Newcastle) worked hard over 10 years to collect 112 epilepsy families in Wales of which 28 qualified for this study. Some of these families had over eight or nine affected individuals which adds to the likelihood of finding new epilepsy genes."

Dr Pickrell added "Epilepsy has a significant effect on people's lives and this project has increased our knowledge on how some kinds of epilepsy run in families. We are looking forward to further results from the study in the future which will may help us develop new epilepsy treatment plans."

###

Notes

* The full findings of the paper 'Phenotypic analysis of 303 multiplex families with common epilepsies' can be found at https://academic.oup.com/brain/article-lookup/doi/10.1093/brain/awx129

* Swansea University Medical School is a UK top-ten Medical School offering a comprehensive portfolio of undergraduate and postgraduate courses spanning medicine, physician associate studies, health and life sciences to meet tomorrow's science and healthcare challenges. Since it beginnings as a newly established Medical School in 2004, it has seen exceptional development from the growth of its Graduate Entry Medicine (GEM) programme to building Wales' premier health and life sciences research facilities in the Institute of Life Science (ILS), Centre for NanoHealth and Data Science Building.

2014 saw the Research Excellence Framework place Swansea University Medical School equal first in the UK for the quality of its research environment and second for overall research quality. In 2016, it became the first department in Swansea University to win Athena SWAN Silver recognition for its work to promote women in science careers. These developments together with significant investment from external funding organisations have led to the Medical School rising to third in the UK in the Complete University Guide 2018 and UK top ten rankings in a range of other independent guides.

Find out more about the Medical School's Strategy for Growth

Find out more about the history of the Medical School

Find out more about the Medical School's success in the 2014 Research Excellence Framework.

Follow us on Twitter: http://www.twitter.com/SwanseaMedicine

Find us on Facebook: http://www.facebook.com/SwanseaMedicine http://www.swansea.ac.uk/medicine

* Swansea University is a world-class, research-led, dual campus university. The University was established in 1920 and was the first campus university in the UK. It currently offers around 350 undergraduate courses and 350 postgraduate courses to circa 20,000 undergraduate and postgraduate students.

The University's 46-acre Singleton Park Campus is located in beautiful parkland with views across Swansea Bay. The University's 65-acre science and innovation Bay Campus, which opened in September 2015, is located a few miles away on the eastern approach to the city. It has the distinction of having direct access to a beach and its own seafront promenade. Both campuses are close to the Gower Peninsula, the UK's first Area of Outstanding Natural Beauty.

Swansea is ranked the top university in Wales and is currently The Times and The Sunday Times 'Welsh University of the Year' for 2017. It is also ranked within the top 300 best universities in the world in the Times Higher Education World University rankings.

The results of the Research Excellence Framework (REF) 2014 showed the University has achieved its ambition to be a top 30 research University, soaring up the league table to 26th in the UK, with the 'biggest leap among research-intensive institutions' (Times Higher Education, December 2014) in the UK.

The University has ambitious expansion plans as it moves towards its centenary in 2020, as it continues to extend its global reach and realising its domestic and international ambitions.

Swansea University is a registered charity. No.1138342. Visit http://www.swansea.ac.uk

For more information, please contact Janis Pickwick, Swansea University Public Relations Office. Tel: 01792 295050, or email: j.m.pickwick@swansea.ac.uk Follow us on Twitter: http://www.twitter.com/SwanseaUni Find us on Facebook: http://www.facebook.com/swanseauniversity

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.